Adjuvant COX Inhibition Augments Cytolytic T Cell Infiltration in Irradiated Triple Negative Breast Tumors
sponsored by Ultivue
February 21, 2023 - 11:00 EST
Immune therapy has emerged as the new frontier of cancer treatment. Therapeutic radiation is a known inducer of an immune response that can be limited by immunosuppressive mediators including cyclooxygenase-2 (COX2), which is highly expressed in triple negative breast tumors.